217 related articles for article (PubMed ID: 24630338)
1. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
[TBL] [Abstract][Full Text] [Related]
2. The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Shishido T; Takahashi H; Funayama A; Narumi T; Kadowaki S; Hasegawa H; Honda S; Netsu S; Ishino M; Arimoto T; Miyashita T; Miyamoto T; Konta T; Kubota I
Circ Heart Fail; 2013 Jul; 6(4):662-8. PubMed ID: 23674363
[TBL] [Abstract][Full Text] [Related]
3. Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Takahashi H; Funayama A; Kinoshita D; Yokoyama M; Takahashi T; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
Clin Res Cardiol; 2016 Feb; 105(2):162-71. PubMed ID: 26220048
[TBL] [Abstract][Full Text] [Related]
4. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Takahashi H; Kadowaki S; Narumi T; Honda Y; Wanezaki M; Sasaki S; Tamura H; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
J Cardiol; 2014 Nov; 64(5):353-9. PubMed ID: 24685687
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease.
Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
ESC Heart Fail; 2023 Aug; 10(4):2458-2468. PubMed ID: 37264723
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
9. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
11. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity.
Franchitto N; Despas F; Labrunee M; Vaccaro A; Lambert E; Lambert G; Galinier M; Senard JM; Pathak A
Int J Cardiol; 2013 Oct; 168(3):2352-7. PubMed ID: 23415171
[TBL] [Abstract][Full Text] [Related]
12. Role of iron deficiency and anemia in cardio-renal syndromes.
Attanasio P; Ronco C; Anker SD; Cicoira M; von Haehling S
Semin Nephrol; 2012 Jan; 32(1):57-62. PubMed ID: 22365163
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal Anemia Syndrome and Survival among Heart Failure Patients in Tanzania: A Prospective Cohort Study.
Pallangyo P; Fredrick F; Bhalia S; Nicholaus P; Kisenge P; Mtinangi B; Janabi M; Humphrey S
BMC Cardiovasc Disord; 2017 Feb; 17(1):59. PubMed ID: 28193165
[TBL] [Abstract][Full Text] [Related]
14. [Hronic heart failure and concomitant diseases in elderly patients: anemia and cardio-renal anemic syndrome].
Larina VN; Bart BIa; Raspopova TN; Larin VG
Kardiologiia; 2014; 54(5):22-8. PubMed ID: 25177883
[TBL] [Abstract][Full Text] [Related]
15. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
Iaina A; Silverberg DS; Wexler D
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
[TBL] [Abstract][Full Text] [Related]
16. Iron deficiency in chronic heart failure: an international pooled analysis.
Klip IT; Comin-Colet J; Voors AA; Ponikowski P; Enjuanes C; Banasiak W; Lok DJ; Rosentryt P; Torrens A; Polonski L; van Veldhuisen DJ; van der Meer P; Jankowska EA
Am Heart J; 2013 Apr; 165(4):575-582.e3. PubMed ID: 23537975
[TBL] [Abstract][Full Text] [Related]
17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
18. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
[TBL] [Abstract][Full Text] [Related]
19. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome.
Silverberg DS; Wexler D; Blum M; Wollman Y; Schwartz D; Sheps D; Keren G; Iaina A
Blood Purif; 2004; 22(3):277-84. PubMed ID: 15166489
[TBL] [Abstract][Full Text] [Related]
20. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
